Top 3 Medical Tech Stocks Set to Thrive Amid Industry Challenges

Avatar photo

The Medical Info Systems industry is rapidly expanding, with artificial intelligence (AI) anticipated to grow at a compound annual growth rate (CAGR) of 38.6% from 2025 to 2030, according to Markets and Markets. A recent survey showed that 79% of health systems increased investments in digital health solutions over the past two years. Notably, the global Smart Healthcare Products market was valued at $280.48 billion in 2024, expected to rise to $796.36 billion by 2032, reflecting a CAGR of 15.37%.

Despite this growth, the industry has underperformed, losing 7.7% over the past year, compared to a 24.7% gain in the Zacks Medical sector and a 17.3% rise in the S&P 500. Currently, the Medical Info Systems industry has a Zacks Industry Rank of #161, placing it in the bottom 34% of 244 industries. The industry’s forward price-to-sales ratio stands at 4.65X, below the S&P 500’s 5.65X.

Leading companies like Doximity, 10x Genomics, and Omnicell are well-positioned to capitalize on the growing market, focusing on enhancing digital health solutions. Doximity, for instance, covers over 80% of U.S. doctors and boasts a 95% subscription-based revenue model. As the sector faces rising cybersecurity threats, effective management and innovation in digital health remain key to navigating these challenges.

The free Daily Market Overview 250k traders and investors are reading

Read Now